Talk:Nevirapine

message: 1.Mechanism of action
2.Clinical use
3.DDIs
4.Toxicity (can go along with DDIs)
5.Adverse Reactions (can go along with DDIs)
6.Prevalence in clinical setting (possibly). 
Possible sources: 
PubMed, Embase, package insert(s) and primary literature cited from drug-info websites such as Micromedex and Lexicomp.  
Sh2018 (talk) 05:28, 3 November 2016 (UTC)
thread_title:  Editing/adding plans from group 17 - student editors

message: I'm deleting point (2), and its corresponding sentence. The pdf relates to NELFINAVIR, not NEVIRAPINE  —Preceding unsigned comment added by 90.192.187.75 (talk) 19:44, 31 January 2008 (UTC)
replies: text: It's been extensively rewritten--largely to add defensive posturing about the risks of all AIDS drugs, the ungroundedness of criticisms, etc., etc--by an IP address from Cornell's med school (User:140.251.12.9).  This happened very shortly after a widely discussed article was published in Harper's Magazine documenting extensive controversy and claims of dishonest behaviour from within the medical community itself regarding the testing and use of Nevirapine.  It's hard not to believe that it was in response to that.  As it stands, it's not suited to an encyclopedia article.  I'm going to cut out as much POV as I can and hope someone with more background can make it otherwise more objective. 136.142.21.210 06:42, 9 April 2006 (UTC)
replies: text:  I've had a go at the article's efficacy & safety data from as neutral a standpoint as I can manage. Espresso Addict 03:42, 18 May 2006 (UTC)
thread_title:  Comments 

message: Can this article be referenced with medical sources and not claims by non-specialists? As long as none of the claims can be attributed to medical journals I tend to call it gossip! Not even the FDA is used as source. Nomen Nescio 03:21, 13 April 2006 (UTC)
replies: text: I've inserted some references to primary papers, as well as up-to-date treatment guidelines and package insert. I haven't found a direct reference for rejection in Canada. My inserted statement on salvage regimens is hard to reference, though I think it's broadly in accordance with the latest tx guidelines. Espresso Addict 03:42, 18 May 2006 (UTC)
replies: text: I've removed the verify tag as I feel the article is now reasonably fully referenced. Espresso Addict 03:22, 17 August 2006 (UTC)
thread_title: References

message: I've rewritten large chunks of this page and provided a lot more information and academic references. The final section (Controversy in Africa) could do with some more work; I'd suggest deleting or relocating the final paragraph, which doesn't relate to NVP, as well as its refs. Any objections?
"During this period, President Mbeki refused international offers of help for South Africa's AIDS epidemic, insisting instead on "African solutions...for African problems." [21] This inaction has itself been blamed the deaths of tens of thousands of people. [22] Mbeki has since backed down from his position that it is poverty, not HIV, that is the primary cause of AIDS, and has opened country to aid from the international community. [23]"
Espresso Addict 10:58, 18 May 2006 (UTC)
thread_title: Amendments 18 May 2006

message: "The U.S. Public Health Service Task Force, however, advocates caution in the use of nevirapine in pregnancy due to toxicity issues, which may be exacerbated during pregnancy.Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States. Public Health Service Task Force. (November 17, 2005) (Available for download from [http://www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=9&ClassID=2 AIDSInfo)"
I removed this text, not because it is technically incorrect, but because it was out of place in the section on use of single-dose nevirapine. This recommendation by the USPHS applies to women (and also men) with higher CD4 counts who are receiving chronic nevirapine therapy, not single-dose prophylaxis.
Jeffreystringer 14:59, 29 July 2007 (UTC)
thread_title: Amendments 29 July 2007

message: 1. Student 1 - Draft has lots of great detailed information about adverse effects, but is not necessarily neutral since it contains a lot of information specific to U.S. prescribing protocol which would not be relevant on a global scale. Leslielai31 (talk) 17:58, 15 November 2016 (UTC)
thread_title:  Review 

message: Hello fellow Wikipedians,
I have just modified one external link on Nevirapine. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
*Added archive https://web.archive.org/web/20090201162348/http://www3.niaid.nih.gov/news/newsreleases/2004/hivnet012.htm to http://www3.niaid.nih.gov/news/newsreleases/2004/hivnet012.htm
When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.
Cheers.—InternetArchiveBot (Report bug) 19:18, 16 February 2018 (UTC)
thread_title:  External links modified (February 2018)